This pipeline computes the correlation between significant copy number variation (cnv focal) genes and selected clinical features.
Testing the association between copy number variation 100 focal events and 7 clinical features across 505 patients, 161 significant findings detected with Q value < 0.25.
-
amp_1p35.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_1p34.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_1p22.3 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_1q21.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_1q22 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_2p24.3 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_2q13 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_3p25.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_3p14.1 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_3q26.2 cnv correlated to 'AGE', 'HISTOLOGICAL.TYPE', and 'RACE'.
-
amp_3q26.2 cnv correlated to 'AGE', 'HISTOLOGICAL.TYPE', and 'RACE'.
-
amp_4p16.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_5p15.33 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_5q35.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_6p24.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_6p22.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_6q25.1 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_7q31.2 cnv correlated to 'Time to Death'.
-
amp_8p11.21 cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.
-
amp_8q24.21 cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.
-
amp_8q24.21 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_9p24.2 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_9q34.3 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_11p11.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_11q13.2 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_11q14.1 cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.
-
amp_12p12.1 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_12q13.11 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_12q13.2 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_13q34 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_14q24.3 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_14q32.33 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_15q26.3 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_16p11.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_17q11.2 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_17q12 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_17q25.1 cnv correlated to 'HISTOLOGICAL.TYPE' and 'RACE'.
-
amp_18p11.31 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_18q11.2 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
amp_19p13.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_19q12 cnv correlated to 'Time to Death', 'AGE', 'HISTOLOGICAL.TYPE', and 'RACE'.
-
amp_20p13 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_20q11.21 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_20q13.12 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_20q13.33 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
amp_22q12.2 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_1p36.21 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_1p36.11 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_2q22.1 cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.
-
del_2q37.3 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_3p14.2 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_3q13.31 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_4p16.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_4p15.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_4q22.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_4q34.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_5q12.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_6q26 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_7p22.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_7q11.22 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_7q31.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_7q36.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_8p23.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_8p21.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_9p23 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_9q21.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_9q34.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_10q23.31 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_11p15.5 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_11q14.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_11q25 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_12q23.1 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_12q24.33 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_13q11 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_13q14.2 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_14q13.1 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_15q15.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_15q23 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_16p13.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_16q21 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_16q22.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_16q23.1 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_17p13.3 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_17p11.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_17q11.2 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_17q21.31 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_18q21.2 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_18q23 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_19p13.3 cnv correlated to 'Time to Death', 'AGE', and 'HISTOLOGICAL.TYPE'.
-
del_19p12 cnv correlated to 'HISTOLOGICAL.TYPE'.
-
del_19q13.43 cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.
-
del_20p12.1 cnv correlated to 'Time to Death'.
-
del_22q13.32 cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
del_xp21.1 cnv correlated to 'Time to Death', 'AGE', and 'HISTOLOGICAL.TYPE'.
Clinical Features |
Time to Death |
AGE |
HISTOLOGICAL TYPE |
RADIATIONS RADIATION REGIMENINDICATION |
COMPLETENESS OF RESECTION |
RACE | ETHNICITY | ||
nCNV (%) | nWild-Type | logrank test | Wilcoxon-test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | |
amp 19q12 | 106 (21%) | 399 |
0.00023 (0.127) |
3e-08 (2.07e-05) |
1e-05 (0.00672) |
0.391 (1.00) |
0.235 (1.00) |
1e-05 (0.00672) |
0.736 (1.00) |
amp 3q26 2 | 158 (31%) | 347 |
0.00607 (1.00) |
3.02e-10 (2.11e-07) |
1e-05 (0.00672) |
0.0853 (1.00) |
0.223 (1.00) |
0.00012 (0.0678) |
0.762 (1.00) |
amp 3q26 2 | 148 (29%) | 357 |
0.00538 (1.00) |
2.42e-08 (1.68e-05) |
1e-05 (0.00672) |
0.124 (1.00) |
0.147 (1.00) |
0.00036 (0.195) |
0.361 (1.00) |
del 19p13 3 | 141 (28%) | 364 |
1.45e-05 (0.00845) |
2.02e-10 (1.42e-07) |
1e-05 (0.00672) |
0.0965 (1.00) |
0.00465 (1.00) |
0.00055 (0.295) |
0.204 (1.00) |
del xp21 1 | 77 (15%) | 428 |
0.000365 (0.198) |
0.000263 (0.145) |
1e-05 (0.00672) |
0.331 (1.00) |
0.12 (1.00) |
0.00462 (1.00) |
0.118 (1.00) |
amp 1p35 2 | 50 (10%) | 455 |
0.13 (1.00) |
0.000249 (0.138) |
1e-05 (0.00672) |
0.621 (1.00) |
0.496 (1.00) |
0.16 (1.00) |
0.334 (1.00) |
amp 1p34 2 | 65 (13%) | 440 |
0.0264 (1.00) |
0.000171 (0.0955) |
1e-05 (0.00672) |
0.299 (1.00) |
0.0431 (1.00) |
0.0458 (1.00) |
0.663 (1.00) |
amp 1q21 3 | 225 (45%) | 280 |
0.0239 (1.00) |
5.29e-05 (0.0302) |
1e-05 (0.00672) |
0.422 (1.00) |
0.697 (1.00) |
0.0106 (1.00) |
0.398 (1.00) |
amp 1q22 | 239 (47%) | 266 |
0.00237 (1.00) |
6.86e-07 (0.000467) |
1e-05 (0.00672) |
0.424 (1.00) |
0.291 (1.00) |
0.0257 (1.00) |
0.577 (1.00) |
amp 2q13 | 109 (22%) | 396 |
0.00151 (0.77) |
0.000358 (0.195) |
1e-05 (0.00672) |
0.397 (1.00) |
0.206 (1.00) |
0.186 (1.00) |
1 (1.00) |
amp 3p25 1 | 78 (15%) | 427 |
0.0443 (1.00) |
0.000359 (0.195) |
1e-05 (0.00672) |
0.0524 (1.00) |
0.781 (1.00) |
0.00342 (1.00) |
0.438 (1.00) |
amp 4p16 3 | 51 (10%) | 454 |
0.329 (1.00) |
1.15e-05 (0.00673) |
1e-05 (0.00672) |
0.741 (1.00) |
0.231 (1.00) |
0.355 (1.00) |
0.334 (1.00) |
amp 5p15 33 | 83 (16%) | 422 |
0.0026 (1.00) |
9.85e-05 (0.056) |
1e-05 (0.00672) |
0.14 (1.00) |
0.156 (1.00) |
0.00325 (1.00) |
0.246 (1.00) |
amp 5q35 3 | 50 (10%) | 455 |
0.0929 (1.00) |
0.00021 (0.116) |
1e-05 (0.00672) |
0.134 (1.00) |
0.465 (1.00) |
0.0241 (1.00) |
0.377 (1.00) |
amp 6p24 2 | 109 (22%) | 396 |
0.31 (1.00) |
2.24e-06 (0.00152) |
1e-05 (0.00672) |
0.0685 (1.00) |
0.74 (1.00) |
0.188 (1.00) |
1 (1.00) |
amp 6p22 3 | 98 (19%) | 407 |
0.971 (1.00) |
0.000166 (0.0927) |
1e-05 (0.00672) |
0.101 (1.00) |
0.491 (1.00) |
0.0151 (1.00) |
0.477 (1.00) |
amp 8p11 21 | 153 (30%) | 352 |
6.02e-05 (0.0343) |
0.843 (1.00) |
1e-05 (0.00672) |
0.0223 (1.00) |
0.00744 (1.00) |
0.256 (1.00) |
0.762 (1.00) |
amp 8q24 21 | 194 (38%) | 311 |
0.000424 (0.229) |
0.057 (1.00) |
1e-05 (0.00672) |
0.00768 (1.00) |
0.21 (1.00) |
0.143 (1.00) |
0.577 (1.00) |
amp 11p11 2 | 48 (10%) | 457 |
0.0153 (1.00) |
0.000132 (0.0744) |
1e-05 (0.00672) |
0.865 (1.00) |
0.428 (1.00) |
0.322 (1.00) |
0.32 (1.00) |
amp 11q14 1 | 54 (11%) | 451 |
0.000188 (0.105) |
0.0165 (1.00) |
1e-05 (0.00672) |
0.147 (1.00) |
0.284 (1.00) |
0.144 (1.00) |
1 (1.00) |
amp 13q34 | 56 (11%) | 449 |
0.396 (1.00) |
5.36e-05 (0.0306) |
1e-05 (0.00672) |
1 (1.00) |
0.0158 (1.00) |
0.0191 (1.00) |
1 (1.00) |
amp 16p11 2 | 62 (12%) | 443 |
0.00287 (1.00) |
0.000351 (0.192) |
1e-05 (0.00672) |
0.447 (1.00) |
0.0968 (1.00) |
0.129 (1.00) |
0.674 (1.00) |
amp 17q25 1 | 94 (19%) | 411 |
0.00487 (1.00) |
0.00106 (0.557) |
1e-05 (0.00672) |
0.524 (1.00) |
0.196 (1.00) |
0.0001 (0.0566) |
0.476 (1.00) |
amp 18p11 31 | 89 (18%) | 416 |
0.0675 (1.00) |
0.000121 (0.0684) |
1e-05 (0.00672) |
0.0178 (1.00) |
0.019 (1.00) |
0.00156 (0.794) |
1 (1.00) |
amp 19p13 2 | 90 (18%) | 415 |
0.0107 (1.00) |
4.21e-10 (2.94e-07) |
1e-05 (0.00672) |
0.0507 (1.00) |
0.242 (1.00) |
0.0011 (0.575) |
1 (1.00) |
amp 20p13 | 110 (22%) | 395 |
0.455 (1.00) |
5.13e-06 (0.00346) |
1e-05 (0.00672) |
0.0296 (1.00) |
0.536 (1.00) |
0.0362 (1.00) |
0.482 (1.00) |
amp 20q11 21 | 140 (28%) | 365 |
0.00209 (1.00) |
7.39e-08 (5.06e-05) |
1e-05 (0.00672) |
0.0139 (1.00) |
0.119 (1.00) |
0.00982 (1.00) |
0.341 (1.00) |
amp 20q13 12 | 140 (28%) | 365 |
0.018 (1.00) |
3.13e-08 (2.16e-05) |
1e-05 (0.00672) |
0.00123 (0.636) |
0.0583 (1.00) |
0.00768 (1.00) |
0.357 (1.00) |
amp 20q13 33 | 138 (27%) | 367 |
0.00992 (1.00) |
4.38e-08 (3.01e-05) |
1e-05 (0.00672) |
0.00237 (1.00) |
0.0173 (1.00) |
0.0784 (1.00) |
0.756 (1.00) |
del 1p36 21 | 64 (13%) | 441 |
0.618 (1.00) |
9.94e-05 (0.0563) |
1e-05 (0.00672) |
0.881 (1.00) |
0.419 (1.00) |
0.108 (1.00) |
0.19 (1.00) |
del 1p36 11 | 74 (15%) | 431 |
0.0586 (1.00) |
4.73e-05 (0.0271) |
1e-05 (0.00672) |
0.575 (1.00) |
0.0233 (1.00) |
0.219 (1.00) |
0.111 (1.00) |
del 2q22 1 | 44 (9%) | 461 |
3.43e-09 (2.39e-06) |
0.00472 (1.00) |
1e-05 (0.00672) |
0.004 (1.00) |
0.00299 (1.00) |
0.0635 (1.00) |
1 (1.00) |
del 4p16 3 | 81 (16%) | 424 |
0.0064 (1.00) |
0.000385 (0.208) |
1e-05 (0.00672) |
0.418 (1.00) |
0.784 (1.00) |
0.328 (1.00) |
0.708 (1.00) |
del 4p15 2 | 83 (16%) | 422 |
0.0072 (1.00) |
0.000164 (0.0917) |
1e-05 (0.00672) |
0.227 (1.00) |
0.362 (1.00) |
0.39 (1.00) |
0.253 (1.00) |
del 4q22 1 | 94 (19%) | 411 |
0.00456 (1.00) |
4.13e-06 (0.0028) |
1e-05 (0.00672) |
0.25 (1.00) |
0.0495 (1.00) |
0.145 (1.00) |
0.712 (1.00) |
del 4q34 3 | 120 (24%) | 385 |
0.0286 (1.00) |
5.71e-07 (0.00039) |
1e-05 (0.00672) |
0.197 (1.00) |
0.132 (1.00) |
0.00636 (1.00) |
1 (1.00) |
del 5q12 1 | 101 (20%) | 404 |
0.0373 (1.00) |
1.22e-05 (0.00709) |
1e-05 (0.00672) |
0.454 (1.00) |
0.644 (1.00) |
0.0626 (1.00) |
0.154 (1.00) |
del 7p22 3 | 67 (13%) | 438 |
0.0023 (1.00) |
0.000132 (0.0743) |
1e-05 (0.00672) |
0.24 (1.00) |
0.303 (1.00) |
0.0777 (1.00) |
0.674 (1.00) |
del 7q11 22 | 39 (8%) | 466 |
0.787 (1.00) |
3.18e-05 (0.0184) |
1e-05 (0.00672) |
0.357 (1.00) |
0.632 (1.00) |
0.361 (1.00) |
1 (1.00) |
del 7q31 1 | 52 (10%) | 453 |
0.0599 (1.00) |
4.75e-05 (0.0272) |
1e-05 (0.00672) |
0.745 (1.00) |
0.497 (1.00) |
0.109 (1.00) |
1 (1.00) |
del 7q36 1 | 61 (12%) | 444 |
0.0112 (1.00) |
2.17e-07 (0.000148) |
1e-05 (0.00672) |
0.88 (1.00) |
0.298 (1.00) |
0.211 (1.00) |
1 (1.00) |
del 8p23 2 | 106 (21%) | 399 |
0.00309 (1.00) |
3.52e-05 (0.0203) |
1e-05 (0.00672) |
0.27 (1.00) |
0.0329 (1.00) |
0.00915 (1.00) |
0.316 (1.00) |
del 8p21 2 | 104 (21%) | 401 |
0.0144 (1.00) |
4.25e-06 (0.00287) |
1e-05 (0.00672) |
0.324 (1.00) |
0.104 (1.00) |
0.0124 (1.00) |
1 (1.00) |
del 9q21 2 | 117 (23%) | 388 |
0.00121 (0.627) |
5.62e-10 (3.92e-07) |
1e-05 (0.00672) |
0.287 (1.00) |
0.175 (1.00) |
0.0629 (1.00) |
0.504 (1.00) |
del 9q34 2 | 119 (24%) | 386 |
0.00716 (1.00) |
3.56e-08 (2.45e-05) |
1e-05 (0.00672) |
0.158 (1.00) |
0.14 (1.00) |
0.148 (1.00) |
1 (1.00) |
del 11p15 5 | 94 (19%) | 411 |
0.0184 (1.00) |
9.43e-06 (0.00634) |
1e-05 (0.00672) |
0.0144 (1.00) |
0.0924 (1.00) |
0.0896 (1.00) |
0.292 (1.00) |
del 11q14 1 | 64 (13%) | 441 |
0.0318 (1.00) |
0.000357 (0.195) |
1e-05 (0.00672) |
0.132 (1.00) |
0.553 (1.00) |
0.0549 (1.00) |
0.026 (1.00) |
del 11q25 | 86 (17%) | 419 |
0.00556 (1.00) |
0.000283 (0.156) |
1e-05 (0.00672) |
0.00506 (1.00) |
0.321 (1.00) |
0.058 (1.00) |
0.708 (1.00) |
del 12q24 33 | 56 (11%) | 449 |
0.0416 (1.00) |
3.82e-05 (0.022) |
1e-05 (0.00672) |
0.0554 (1.00) |
0.0395 (1.00) |
0.386 (1.00) |
1 (1.00) |
del 15q15 1 | 128 (25%) | 377 |
0.00159 (0.81) |
4.08e-08 (2.81e-05) |
1e-05 (0.00672) |
0.0116 (1.00) |
0.0372 (1.00) |
0.0451 (1.00) |
1 (1.00) |
del 15q23 | 107 (21%) | 398 |
0.0341 (1.00) |
1.23e-05 (0.00713) |
1e-05 (0.00672) |
0.0873 (1.00) |
0.377 (1.00) |
0.0368 (1.00) |
0.315 (1.00) |
del 16p13 3 | 83 (16%) | 422 |
0.0263 (1.00) |
1.33e-06 (0.000904) |
1e-05 (0.00672) |
0.14 (1.00) |
0.106 (1.00) |
0.0256 (1.00) |
1 (1.00) |
del 16q21 | 141 (28%) | 364 |
0.0308 (1.00) |
2.59e-08 (1.79e-05) |
1e-05 (0.00672) |
0.181 (1.00) |
0.214 (1.00) |
0.0236 (1.00) |
1 (1.00) |
del 16q22 3 | 144 (29%) | 361 |
0.0891 (1.00) |
1.78e-08 (1.23e-05) |
1e-05 (0.00672) |
0.269 (1.00) |
0.182 (1.00) |
0.0339 (1.00) |
1 (1.00) |
del 16q23 1 | 152 (30%) | 353 |
0.00932 (1.00) |
2.47e-08 (1.71e-05) |
1e-05 (0.00672) |
0.276 (1.00) |
0.0157 (1.00) |
0.00261 (1.00) |
1 (1.00) |
del 17p13 3 | 110 (22%) | 395 |
0.0015 (0.769) |
0.000294 (0.161) |
1e-05 (0.00672) |
0.0917 (1.00) |
0.156 (1.00) |
0.00453 (1.00) |
1 (1.00) |
del 17p11 2 | 115 (23%) | 390 |
0.00153 (0.778) |
5.37e-06 (0.00362) |
1e-05 (0.00672) |
0.153 (1.00) |
0.515 (1.00) |
0.0328 (1.00) |
1 (1.00) |
del 17q11 2 | 95 (19%) | 410 |
0.0676 (1.00) |
1.13e-06 (0.000771) |
1e-05 (0.00672) |
0.159 (1.00) |
0.201 (1.00) |
0.791 (1.00) |
0.717 (1.00) |
del 17q21 31 | 100 (20%) | 405 |
0.00166 (0.84) |
1.77e-05 (0.0103) |
1e-05 (0.00672) |
0.133 (1.00) |
0.0353 (1.00) |
0.222 (1.00) |
0.0248 (1.00) |
del 19q13 43 | 58 (11%) | 447 |
0.00029 (0.16) |
0.000967 (0.508) |
1e-05 (0.00672) |
0.64 (1.00) |
0.0345 (1.00) |
0.367 (1.00) |
0.154 (1.00) |
del 22q13 32 | 129 (26%) | 376 |
0.00552 (1.00) |
4.3e-08 (2.95e-05) |
1e-05 (0.00672) |
0.0218 (1.00) |
0.308 (1.00) |
0.0131 (1.00) |
0.121 (1.00) |
amp 1p22 3 | 90 (18%) | 415 |
0.466 (1.00) |
0.00188 (0.942) |
0.00033 (0.181) |
0.602 (1.00) |
0.908 (1.00) |
0.434 (1.00) |
0.138 (1.00) |
amp 2p24 3 | 112 (22%) | 393 |
0.000688 (0.368) |
0.0192 (1.00) |
1e-05 (0.00672) |
0.0412 (1.00) |
0.823 (1.00) |
0.446 (1.00) |
0.314 (1.00) |
amp 3p14 1 | 60 (12%) | 445 |
0.000777 (0.412) |
0.0103 (1.00) |
4e-05 (0.023) |
0.021 (1.00) |
0.263 (1.00) |
0.0155 (1.00) |
0.0551 (1.00) |
amp 6q25 1 | 80 (16%) | 425 |
0.358 (1.00) |
0.00353 (1.00) |
1e-05 (0.00672) |
0.339 (1.00) |
0.297 (1.00) |
0.00789 (1.00) |
0.701 (1.00) |
amp 7q31 2 | 82 (16%) | 423 |
5.15e-07 (0.000352) |
0.118 (1.00) |
0.00184 (0.922) |
0.0218 (1.00) |
0.377 (1.00) |
0.791 (1.00) |
0.479 (1.00) |
amp 8q24 21 | 200 (40%) | 305 |
0.000789 (0.417) |
0.0205 (1.00) |
1e-05 (0.00672) |
0.0058 (1.00) |
0.0118 (1.00) |
0.549 (1.00) |
1 (1.00) |
amp 9p24 2 | 61 (12%) | 444 |
0.0223 (1.00) |
0.00166 (0.84) |
1e-05 (0.00672) |
0.17 (1.00) |
0.342 (1.00) |
0.103 (1.00) |
0.0141 (1.00) |
amp 9q34 3 | 37 (7%) | 468 |
0.0146 (1.00) |
0.00163 (0.824) |
1e-05 (0.00672) |
1 (1.00) |
0.269 (1.00) |
0.00909 (1.00) |
1 (1.00) |
amp 11q13 2 | 67 (13%) | 438 |
0.0494 (1.00) |
0.000902 (0.475) |
1e-05 (0.00672) |
0.558 (1.00) |
0.222 (1.00) |
0.744 (1.00) |
1 (1.00) |
amp 12p12 1 | 86 (17%) | 419 |
0.697 (1.00) |
0.104 (1.00) |
1e-05 (0.00672) |
0.426 (1.00) |
0.618 (1.00) |
0.0978 (1.00) |
0.136 (1.00) |
amp 12q13 11 | 81 (16%) | 424 |
0.503 (1.00) |
0.639 (1.00) |
1e-05 (0.00672) |
0.104 (1.00) |
0.392 (1.00) |
0.00821 (1.00) |
0.703 (1.00) |
amp 12q13 2 | 92 (18%) | 413 |
0.541 (1.00) |
0.0859 (1.00) |
1e-05 (0.00672) |
0.0384 (1.00) |
0.0836 (1.00) |
0.0738 (1.00) |
1 (1.00) |
amp 14q24 3 | 59 (12%) | 446 |
0.000753 (0.4) |
0.00133 (0.685) |
1e-05 (0.00672) |
0.122 (1.00) |
0.365 (1.00) |
0.491 (1.00) |
0.653 (1.00) |
amp 14q32 33 | 72 (14%) | 433 |
0.076 (1.00) |
0.000505 (0.272) |
1e-05 (0.00672) |
0.0146 (1.00) |
0.211 (1.00) |
0.0091 (1.00) |
0.702 (1.00) |
amp 15q26 3 | 36 (7%) | 469 |
0.0383 (1.00) |
0.00511 (1.00) |
0.00015 (0.084) |
0.0791 (1.00) |
0.0101 (1.00) |
0.796 (1.00) |
0.32 (1.00) |
amp 17q11 2 | 68 (13%) | 437 |
0.0288 (1.00) |
0.00583 (1.00) |
1e-05 (0.00672) |
0.38 (1.00) |
0.00125 (0.646) |
0.00544 (1.00) |
0.22 (1.00) |
amp 17q12 | 69 (14%) | 436 |
0.00232 (1.00) |
0.00128 (0.661) |
1e-05 (0.00672) |
1 (1.00) |
0.173 (1.00) |
0.00805 (1.00) |
1 (1.00) |
amp 18q11 2 | 64 (13%) | 441 |
0.0337 (1.00) |
0.00177 (0.891) |
1e-05 (0.00672) |
0.368 (1.00) |
0.0296 (1.00) |
0.00427 (1.00) |
1 (1.00) |
amp 22q12 2 | 58 (11%) | 447 |
0.00178 (0.895) |
0.000742 (0.395) |
1e-05 (0.00672) |
0.0841 (1.00) |
0.00092 (0.484) |
0.0118 (1.00) |
0.653 (1.00) |
del 2q37 3 | 49 (10%) | 456 |
0.0648 (1.00) |
0.00327 (1.00) |
0.00014 (0.0785) |
0.177 (1.00) |
0.063 (1.00) |
0.116 (1.00) |
1 (1.00) |
del 3p14 2 | 69 (14%) | 436 |
0.149 (1.00) |
0.00071 (0.379) |
1e-05 (0.00672) |
0.469 (1.00) |
0.72 (1.00) |
0.0471 (1.00) |
0.229 (1.00) |
del 3q13 31 | 40 (8%) | 465 |
0.37 (1.00) |
0.000718 (0.383) |
2e-05 (0.0116) |
0.356 (1.00) |
0.855 (1.00) |
0.805 (1.00) |
0.611 (1.00) |
del 6q26 | 43 (9%) | 462 |
0.25 (1.00) |
0.00543 (1.00) |
1e-05 (0.00672) |
0.596 (1.00) |
0.949 (1.00) |
0.806 (1.00) |
0.611 (1.00) |
del 9p23 | 70 (14%) | 435 |
0.179 (1.00) |
0.00272 (1.00) |
1e-05 (0.00672) |
0.0837 (1.00) |
0.25 (1.00) |
0.173 (1.00) |
1 (1.00) |
del 10q23 31 | 68 (13%) | 437 |
0.0856 (1.00) |
0.000608 (0.326) |
1e-05 (0.00672) |
0.0124 (1.00) |
0.111 (1.00) |
0.306 (1.00) |
0.685 (1.00) |
del 12q23 1 | 46 (9%) | 459 |
0.0129 (1.00) |
0.0024 (1.00) |
1e-05 (0.00672) |
0.122 (1.00) |
0.0229 (1.00) |
0.0344 (1.00) |
1 (1.00) |
del 13q11 | 86 (17%) | 419 |
0.014 (1.00) |
0.00124 (0.642) |
1e-05 (0.00672) |
0.11 (1.00) |
0.161 (1.00) |
0.184 (1.00) |
0.257 (1.00) |
del 13q14 2 | 93 (18%) | 412 |
0.0244 (1.00) |
0.00193 (0.964) |
1e-05 (0.00672) |
0.0146 (1.00) |
0.44 (1.00) |
0.142 (1.00) |
0.151 (1.00) |
del 14q13 1 | 67 (13%) | 438 |
0.0122 (1.00) |
0.00407 (1.00) |
1e-05 (0.00672) |
0.379 (1.00) |
0.966 (1.00) |
0.00683 (1.00) |
0.22 (1.00) |
del 18q21 2 | 82 (16%) | 423 |
0.654 (1.00) |
0.000777 (0.412) |
1e-05 (0.00672) |
0.0101 (1.00) |
0.141 (1.00) |
0.048 (1.00) |
0.253 (1.00) |
del 18q23 | 87 (17%) | 418 |
0.00809 (1.00) |
0.00113 (0.589) |
1e-05 (0.00672) |
0.00143 (0.735) |
0.00978 (1.00) |
0.0698 (1.00) |
0.0596 (1.00) |
del 19p12 | 52 (10%) | 453 |
0.0238 (1.00) |
0.0203 (1.00) |
1e-05 (0.00672) |
0.048 (1.00) |
0.119 (1.00) |
0.0679 (1.00) |
0.635 (1.00) |
del 20p12 1 | 31 (6%) | 474 |
1.98e-05 (0.0115) |
0.226 (1.00) |
0.00047 (0.253) |
0.836 (1.00) |
0.0491 (1.00) |
0.263 (1.00) |
0.237 (1.00) |
amp 1q44 | 202 (40%) | 303 |
0.148 (1.00) |
0.00342 (1.00) |
0.623 (1.00) |
0.839 (1.00) |
0.571 (1.00) |
0.354 (1.00) |
0.255 (1.00) |
amp 8p11 22 | 120 (24%) | 385 |
0.0216 (1.00) |
0.144 (1.00) |
0.843 (1.00) |
0.292 (1.00) |
0.706 (1.00) |
0.367 (1.00) |
0.529 (1.00) |
amp 10q22 2 | 136 (27%) | 369 |
0.329 (1.00) |
0.361 (1.00) |
0.00179 (0.899) |
0.501 (1.00) |
0.583 (1.00) |
0.558 (1.00) |
1 (1.00) |
amp xp11 23 | 82 (16%) | 423 |
0.198 (1.00) |
0.131 (1.00) |
0.00119 (0.62) |
0.0573 (1.00) |
0.542 (1.00) |
0.983 (1.00) |
0.704 (1.00) |
amp xq28 | 83 (16%) | 422 |
0.00132 (0.681) |
0.129 (1.00) |
0.00281 (1.00) |
0.894 (1.00) |
0.209 (1.00) |
0.569 (1.00) |
0.445 (1.00) |
del 2p25 3 | 25 (5%) | 480 |
0.0387 (1.00) |
0.0456 (1.00) |
0.00615 (1.00) |
0.105 (1.00) |
0.286 (1.00) |
0.337 (1.00) |
1 (1.00) |
P value = 0.000249 (Wilcoxon-test), Q value = 0.14
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 1(1P35.2) MUTATED | 50 | 68.6 (9.0) |
AMP PEAK 1(1P35.2) WILD-TYPE | 454 | 63.3 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 1(1P35.2) MUTATED | 14 | 5 | 31 |
AMP PEAK 1(1P35.2) WILD-TYPE | 366 | 16 | 73 |
P value = 0.000171 (Wilcoxon-test), Q value = 0.095
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 2(1P34.2) MUTATED | 65 | 68.5 (9.7) |
AMP PEAK 2(1P34.2) WILD-TYPE | 439 | 63.2 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 2(1P34.2) MUTATED | 19 | 7 | 39 |
AMP PEAK 2(1P34.2) WILD-TYPE | 361 | 14 | 65 |
P value = 0.00033 (Fisher's exact test), Q value = 0.18
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 3(1P22.3) MUTATED | 53 | 5 | 32 |
AMP PEAK 3(1P22.3) WILD-TYPE | 327 | 16 | 72 |
P value = 5.29e-05 (Wilcoxon-test), Q value = 0.03
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 4(1Q21.3) MUTATED | 225 | 66.2 (10.3) |
AMP PEAK 4(1Q21.3) WILD-TYPE | 279 | 61.9 (11.6) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 4(1Q21.3) MUTATED | 148 | 10 | 67 |
AMP PEAK 4(1Q21.3) WILD-TYPE | 232 | 11 | 37 |
P value = 6.86e-07 (Wilcoxon-test), Q value = 0.00047
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 5(1Q22) MUTATED | 239 | 66.5 (10.4) |
AMP PEAK 5(1Q22) WILD-TYPE | 265 | 61.4 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 5(1Q22) MUTATED | 155 | 10 | 74 |
AMP PEAK 5(1Q22) WILD-TYPE | 225 | 11 | 30 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 7(2P24.3) MUTATED | 53 | 7 | 52 |
AMP PEAK 7(2P24.3) WILD-TYPE | 327 | 14 | 52 |
P value = 0.000358 (Wilcoxon-test), Q value = 0.19
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 8(2Q13) MUTATED | 108 | 66.9 (9.1) |
AMP PEAK 8(2Q13) WILD-TYPE | 396 | 63.0 (11.6) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 8(2Q13) MUTATED | 43 | 5 | 61 |
AMP PEAK 8(2Q13) WILD-TYPE | 337 | 16 | 43 |
P value = 0.000359 (Wilcoxon-test), Q value = 0.2
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 9(3P25.1) MUTATED | 78 | 68.3 (10.5) |
AMP PEAK 9(3P25.1) WILD-TYPE | 426 | 63.0 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 9(3P25.1) MUTATED | 34 | 1 | 43 |
AMP PEAK 9(3P25.1) WILD-TYPE | 346 | 20 | 61 |
P value = 4e-05 (Fisher's exact test), Q value = 0.023
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 10(3P14.1) MUTATED | 31 | 3 | 26 |
AMP PEAK 10(3P14.1) WILD-TYPE | 349 | 18 | 78 |
P value = 3.02e-10 (Wilcoxon-test), Q value = 2.1e-07
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 11(3Q26.2) MUTATED | 158 | 68.2 (9.4) |
AMP PEAK 11(3Q26.2) WILD-TYPE | 346 | 61.9 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 11(3Q26.2) MUTATED | 68 | 8 | 82 |
AMP PEAK 11(3Q26.2) WILD-TYPE | 312 | 13 | 22 |
P value = 0.00012 (Fisher's exact test), Q value = 0.068
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 19 | 90 | 9 | 357 |
AMP PEAK 11(3Q26.2) MUTATED | 0 | 3 | 45 | 4 | 95 |
AMP PEAK 11(3Q26.2) WILD-TYPE | 4 | 16 | 45 | 5 | 262 |
P value = 2.42e-08 (Wilcoxon-test), Q value = 1.7e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 12(3Q26.2) MUTATED | 148 | 67.9 (9.4) |
AMP PEAK 12(3Q26.2) WILD-TYPE | 356 | 62.1 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 12(3Q26.2) MUTATED | 61 | 7 | 80 |
AMP PEAK 12(3Q26.2) WILD-TYPE | 319 | 14 | 24 |
P value = 0.00036 (Fisher's exact test), Q value = 0.2
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 19 | 90 | 9 | 357 |
AMP PEAK 12(3Q26.2) MUTATED | 0 | 3 | 42 | 4 | 89 |
AMP PEAK 12(3Q26.2) WILD-TYPE | 4 | 16 | 48 | 5 | 268 |
P value = 1.15e-05 (Wilcoxon-test), Q value = 0.0067
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 13(4P16.3) MUTATED | 51 | 69.8 (9.0) |
AMP PEAK 13(4P16.3) WILD-TYPE | 453 | 63.2 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 13(4P16.3) MUTATED | 15 | 1 | 35 |
AMP PEAK 13(4P16.3) WILD-TYPE | 365 | 20 | 69 |
P value = 9.85e-05 (Wilcoxon-test), Q value = 0.056
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 14(5P15.33) MUTATED | 83 | 67.6 (10.1) |
AMP PEAK 14(5P15.33) WILD-TYPE | 421 | 63.1 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 14(5P15.33) MUTATED | 28 | 3 | 52 |
AMP PEAK 14(5P15.33) WILD-TYPE | 352 | 18 | 52 |
P value = 0.00021 (Wilcoxon-test), Q value = 0.12
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 15(5Q35.3) MUTATED | 50 | 69.3 (10.3) |
AMP PEAK 15(5Q35.3) WILD-TYPE | 454 | 63.2 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 15(5Q35.3) MUTATED | 19 | 2 | 29 |
AMP PEAK 15(5Q35.3) WILD-TYPE | 361 | 19 | 75 |
P value = 2.24e-06 (Wilcoxon-test), Q value = 0.0015
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 16(6P24.2) MUTATED | 109 | 68.0 (9.8) |
AMP PEAK 16(6P24.2) WILD-TYPE | 395 | 62.7 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 16(6P24.2) MUTATED | 42 | 5 | 62 |
AMP PEAK 16(6P24.2) WILD-TYPE | 338 | 16 | 42 |
P value = 0.000166 (Wilcoxon-test), Q value = 0.093
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 17(6P22.3) MUTATED | 98 | 67.3 (9.9) |
AMP PEAK 17(6P22.3) WILD-TYPE | 406 | 63.0 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 17(6P22.3) MUTATED | 37 | 4 | 57 |
AMP PEAK 17(6P22.3) WILD-TYPE | 343 | 17 | 47 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 18(6Q25.1) MUTATED | 42 | 2 | 36 |
AMP PEAK 18(6Q25.1) WILD-TYPE | 338 | 19 | 68 |
P value = 5.15e-07 (logrank test), Q value = 0.00035
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 503 | 60 | 0.0 - 191.8 (22.8) |
AMP PEAK 19(7Q31.2) MUTATED | 81 | 21 | 0.0 - 125.4 (16.0) |
AMP PEAK 19(7Q31.2) WILD-TYPE | 422 | 39 | 0.1 - 191.8 (23.9) |
P value = 6.02e-05 (logrank test), Q value = 0.034
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 503 | 60 | 0.0 - 191.8 (22.8) |
AMP PEAK 21(8P11.21) MUTATED | 152 | 30 | 0.0 - 125.4 (19.3) |
AMP PEAK 21(8P11.21) WILD-TYPE | 351 | 30 | 0.1 - 191.8 (24.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 21(8P11.21) MUTATED | 90 | 7 | 56 |
AMP PEAK 21(8P11.21) WILD-TYPE | 290 | 14 | 48 |
P value = 0.000424 (logrank test), Q value = 0.23
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 503 | 60 | 0.0 - 191.8 (22.8) |
AMP PEAK 22(8Q24.21) MUTATED | 193 | 34 | 0.0 - 191.8 (19.3) |
AMP PEAK 22(8Q24.21) WILD-TYPE | 310 | 26 | 0.1 - 185.8 (24.5) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 22(8Q24.21) MUTATED | 109 | 10 | 75 |
AMP PEAK 22(8Q24.21) WILD-TYPE | 271 | 11 | 29 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 23(8Q24.21) MUTATED | 112 | 9 | 79 |
AMP PEAK 23(8Q24.21) WILD-TYPE | 268 | 12 | 25 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 24(9P24.2) MUTATED | 23 | 3 | 35 |
AMP PEAK 24(9P24.2) WILD-TYPE | 357 | 18 | 69 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 25(9Q34.3) MUTATED | 12 | 4 | 21 |
AMP PEAK 25(9Q34.3) WILD-TYPE | 368 | 17 | 83 |
P value = 0.000132 (Wilcoxon-test), Q value = 0.074
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 27(11P11.2) MUTATED | 48 | 69.8 (9.6) |
AMP PEAK 27(11P11.2) WILD-TYPE | 456 | 63.2 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 27(11P11.2) MUTATED | 16 | 4 | 28 |
AMP PEAK 27(11P11.2) WILD-TYPE | 364 | 17 | 76 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 28(11Q13.2) MUTATED | 31 | 3 | 33 |
AMP PEAK 28(11Q13.2) WILD-TYPE | 349 | 18 | 71 |
P value = 0.000188 (logrank test), Q value = 0.1
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 503 | 60 | 0.0 - 191.8 (22.8) |
AMP PEAK 29(11Q14.1) MUTATED | 54 | 14 | 0.0 - 102.3 (19.3) |
AMP PEAK 29(11Q14.1) WILD-TYPE | 449 | 46 | 0.1 - 191.8 (23.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 29(11Q14.1) MUTATED | 20 | 1 | 33 |
AMP PEAK 29(11Q14.1) WILD-TYPE | 360 | 20 | 71 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 30(12P12.1) MUTATED | 41 | 4 | 41 |
AMP PEAK 30(12P12.1) WILD-TYPE | 339 | 17 | 63 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 31(12Q13.11) MUTATED | 38 | 4 | 39 |
AMP PEAK 31(12Q13.11) WILD-TYPE | 342 | 17 | 65 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 32(12Q13.2) MUTATED | 47 | 4 | 41 |
AMP PEAK 32(12Q13.2) WILD-TYPE | 333 | 17 | 63 |
P value = 5.36e-05 (Wilcoxon-test), Q value = 0.031
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 33(13Q34) MUTATED | 56 | 69.1 (7.5) |
AMP PEAK 33(13Q34) WILD-TYPE | 448 | 63.2 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 33(13Q34) MUTATED | 14 | 4 | 38 |
AMP PEAK 33(13Q34) WILD-TYPE | 366 | 17 | 66 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 34(14Q24.3) MUTATED | 20 | 4 | 35 |
AMP PEAK 34(14Q24.3) WILD-TYPE | 360 | 17 | 69 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 35(14Q32.33) MUTATED | 29 | 5 | 38 |
AMP PEAK 35(14Q32.33) WILD-TYPE | 351 | 16 | 66 |
P value = 0.00015 (Fisher's exact test), Q value = 0.084
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 36(15Q26.3) MUTATED | 17 | 1 | 18 |
AMP PEAK 36(15Q26.3) WILD-TYPE | 363 | 20 | 86 |
P value = 0.000351 (Wilcoxon-test), Q value = 0.19
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 37(16P11.2) MUTATED | 62 | 68.3 (9.0) |
AMP PEAK 37(16P11.2) WILD-TYPE | 442 | 63.2 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 37(16P11.2) MUTATED | 20 | 2 | 40 |
AMP PEAK 37(16P11.2) WILD-TYPE | 360 | 19 | 64 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 38(17Q11.2) MUTATED | 16 | 6 | 46 |
AMP PEAK 38(17Q11.2) WILD-TYPE | 364 | 15 | 58 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 39(17Q12) MUTATED | 18 | 3 | 48 |
AMP PEAK 39(17Q12) WILD-TYPE | 362 | 18 | 56 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 40(17Q25.1) MUTATED | 34 | 9 | 51 |
AMP PEAK 40(17Q25.1) WILD-TYPE | 346 | 12 | 53 |
P value = 1e-04 (Fisher's exact test), Q value = 0.057
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 19 | 90 | 9 | 357 |
AMP PEAK 40(17Q25.1) MUTATED | 0 | 0 | 32 | 2 | 56 |
AMP PEAK 40(17Q25.1) WILD-TYPE | 4 | 19 | 58 | 7 | 301 |
P value = 0.000121 (Wilcoxon-test), Q value = 0.068
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 41(18P11.31) MUTATED | 89 | 67.7 (9.1) |
AMP PEAK 41(18P11.31) WILD-TYPE | 415 | 63.0 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 41(18P11.31) MUTATED | 27 | 6 | 56 |
AMP PEAK 41(18P11.31) WILD-TYPE | 353 | 15 | 48 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 42(18Q11.2) MUTATED | 18 | 4 | 42 |
AMP PEAK 42(18Q11.2) WILD-TYPE | 362 | 17 | 62 |
P value = 4.21e-10 (Wilcoxon-test), Q value = 2.9e-07
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 43(19P13.2) MUTATED | 90 | 70.2 (8.6) |
AMP PEAK 43(19P13.2) WILD-TYPE | 414 | 62.5 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 43(19P13.2) MUTATED | 23 | 7 | 60 |
AMP PEAK 43(19P13.2) WILD-TYPE | 357 | 14 | 44 |
P value = 0.00023 (logrank test), Q value = 0.13
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 503 | 60 | 0.0 - 191.8 (22.8) |
AMP PEAK 44(19Q12) MUTATED | 106 | 22 | 0.0 - 125.4 (18.1) |
AMP PEAK 44(19Q12) WILD-TYPE | 397 | 38 | 0.1 - 191.8 (23.5) |
P value = 3e-08 (Wilcoxon-test), Q value = 2.1e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 44(19Q12) MUTATED | 106 | 68.8 (8.6) |
AMP PEAK 44(19Q12) WILD-TYPE | 398 | 62.5 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 44(19Q12) MUTATED | 25 | 10 | 71 |
AMP PEAK 44(19Q12) WILD-TYPE | 355 | 11 | 33 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 19 | 90 | 9 | 357 |
AMP PEAK 44(19Q12) MUTATED | 1 | 2 | 38 | 3 | 57 |
AMP PEAK 44(19Q12) WILD-TYPE | 3 | 17 | 52 | 6 | 300 |
P value = 5.13e-06 (Wilcoxon-test), Q value = 0.0035
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 45(20P13) MUTATED | 110 | 67.7 (11.0) |
AMP PEAK 45(20P13) WILD-TYPE | 394 | 62.8 (11.1) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 45(20P13) MUTATED | 50 | 5 | 55 |
AMP PEAK 45(20P13) WILD-TYPE | 330 | 16 | 49 |
P value = 7.39e-08 (Wilcoxon-test), Q value = 5.1e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 46(20Q11.21) MUTATED | 140 | 67.9 (9.8) |
AMP PEAK 46(20Q11.21) WILD-TYPE | 364 | 62.3 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 46(20Q11.21) MUTATED | 58 | 6 | 76 |
AMP PEAK 46(20Q11.21) WILD-TYPE | 322 | 15 | 28 |
P value = 3.13e-08 (Wilcoxon-test), Q value = 2.2e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 47(20Q13.12) MUTATED | 140 | 68.1 (10.1) |
AMP PEAK 47(20Q13.12) WILD-TYPE | 364 | 62.2 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 47(20Q13.12) MUTATED | 60 | 7 | 73 |
AMP PEAK 47(20Q13.12) WILD-TYPE | 320 | 14 | 31 |
P value = 4.38e-08 (Wilcoxon-test), Q value = 3e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
AMP PEAK 48(20Q13.33) MUTATED | 138 | 68.1 (10.2) |
AMP PEAK 48(20Q13.33) WILD-TYPE | 366 | 62.2 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 48(20Q13.33) MUTATED | 61 | 6 | 71 |
AMP PEAK 48(20Q13.33) WILD-TYPE | 319 | 15 | 33 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
AMP PEAK 49(22Q12.2) MUTATED | 11 | 2 | 45 |
AMP PEAK 49(22Q12.2) WILD-TYPE | 369 | 19 | 59 |
P value = 9.94e-05 (Wilcoxon-test), Q value = 0.056
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 1(1P36.21) MUTATED | 64 | 69.4 (10.5) |
DEL PEAK 1(1P36.21) WILD-TYPE | 440 | 63.0 (11.1) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 1(1P36.21) MUTATED | 26 | 5 | 33 |
DEL PEAK 1(1P36.21) WILD-TYPE | 354 | 16 | 71 |
P value = 4.73e-05 (Wilcoxon-test), Q value = 0.027
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 2(1P36.11) MUTATED | 74 | 68.9 (9.6) |
DEL PEAK 2(1P36.11) WILD-TYPE | 430 | 63.0 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 2(1P36.11) MUTATED | 24 | 5 | 45 |
DEL PEAK 2(1P36.11) WILD-TYPE | 356 | 16 | 59 |
P value = 3.43e-09 (logrank test), Q value = 2.4e-06
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 503 | 60 | 0.0 - 191.8 (22.8) |
DEL PEAK 4(2Q22.1) MUTATED | 44 | 15 | 0.5 - 125.4 (11.3) |
DEL PEAK 4(2Q22.1) WILD-TYPE | 459 | 45 | 0.0 - 191.8 (23.9) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 4(2Q22.1) MUTATED | 16 | 2 | 26 |
DEL PEAK 4(2Q22.1) WILD-TYPE | 364 | 19 | 78 |
P value = 0.00014 (Fisher's exact test), Q value = 0.079
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 5(2Q37.3) MUTATED | 25 | 2 | 22 |
DEL PEAK 5(2Q37.3) WILD-TYPE | 355 | 19 | 82 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 6(3P14.2) MUTATED | 23 | 6 | 40 |
DEL PEAK 6(3P14.2) WILD-TYPE | 357 | 15 | 64 |
P value = 2e-05 (Fisher's exact test), Q value = 0.012
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 7(3Q13.31) MUTATED | 17 | 3 | 20 |
DEL PEAK 7(3Q13.31) WILD-TYPE | 363 | 18 | 84 |
P value = 0.000385 (Wilcoxon-test), Q value = 0.21
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 8(4P16.3) MUTATED | 81 | 67.9 (9.1) |
DEL PEAK 8(4P16.3) WILD-TYPE | 423 | 63.1 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 8(4P16.3) MUTATED | 28 | 5 | 48 |
DEL PEAK 8(4P16.3) WILD-TYPE | 352 | 16 | 56 |
P value = 0.000164 (Wilcoxon-test), Q value = 0.092
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 9(4P15.2) MUTATED | 83 | 68.1 (9.2) |
DEL PEAK 9(4P15.2) WILD-TYPE | 421 | 63.0 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 9(4P15.2) MUTATED | 29 | 5 | 49 |
DEL PEAK 9(4P15.2) WILD-TYPE | 351 | 16 | 55 |
P value = 4.13e-06 (Wilcoxon-test), Q value = 0.0028
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 10(4Q22.1) MUTATED | 94 | 68.5 (9.1) |
DEL PEAK 10(4Q22.1) WILD-TYPE | 410 | 62.8 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 10(4Q22.1) MUTATED | 28 | 6 | 60 |
DEL PEAK 10(4Q22.1) WILD-TYPE | 352 | 15 | 44 |
P value = 5.71e-07 (Wilcoxon-test), Q value = 0.00039
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 11(4Q34.3) MUTATED | 120 | 68.0 (9.9) |
DEL PEAK 11(4Q34.3) WILD-TYPE | 384 | 62.5 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 11(4Q34.3) MUTATED | 41 | 8 | 71 |
DEL PEAK 11(4Q34.3) WILD-TYPE | 339 | 13 | 33 |
P value = 1.22e-05 (Wilcoxon-test), Q value = 0.0071
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 12(5Q12.1) MUTATED | 101 | 67.7 (9.8) |
DEL PEAK 12(5Q12.1) WILD-TYPE | 403 | 62.9 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 12(5Q12.1) MUTATED | 32 | 4 | 65 |
DEL PEAK 12(5Q12.1) WILD-TYPE | 348 | 17 | 39 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 13(6Q26) MUTATED | 12 | 3 | 28 |
DEL PEAK 13(6Q26) WILD-TYPE | 368 | 18 | 76 |
P value = 0.000132 (Wilcoxon-test), Q value = 0.074
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 14(7P22.3) MUTATED | 66 | 68.5 (10.1) |
DEL PEAK 14(7P22.3) WILD-TYPE | 438 | 63.1 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 14(7P22.3) MUTATED | 21 | 5 | 41 |
DEL PEAK 14(7P22.3) WILD-TYPE | 359 | 16 | 63 |
P value = 3.18e-05 (Wilcoxon-test), Q value = 0.018
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 15(7Q11.22) MUTATED | 39 | 70.7 (9.8) |
DEL PEAK 15(7Q11.22) WILD-TYPE | 465 | 63.3 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 15(7Q11.22) MUTATED | 13 | 2 | 24 |
DEL PEAK 15(7Q11.22) WILD-TYPE | 367 | 19 | 80 |
P value = 4.75e-05 (Wilcoxon-test), Q value = 0.027
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 16(7Q31.1) MUTATED | 52 | 69.4 (7.9) |
DEL PEAK 16(7Q31.1) WILD-TYPE | 452 | 63.2 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 16(7Q31.1) MUTATED | 9 | 3 | 40 |
DEL PEAK 16(7Q31.1) WILD-TYPE | 371 | 18 | 64 |
P value = 2.17e-07 (Wilcoxon-test), Q value = 0.00015
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 17(7Q36.1) MUTATED | 61 | 70.6 (8.6) |
DEL PEAK 17(7Q36.1) WILD-TYPE | 443 | 62.9 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 17(7Q36.1) MUTATED | 12 | 4 | 45 |
DEL PEAK 17(7Q36.1) WILD-TYPE | 368 | 17 | 59 |
P value = 3.52e-05 (Wilcoxon-test), Q value = 0.02
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 18(8P23.2) MUTATED | 105 | 67.4 (9.3) |
DEL PEAK 18(8P23.2) WILD-TYPE | 399 | 62.9 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 18(8P23.2) MUTATED | 31 | 5 | 70 |
DEL PEAK 18(8P23.2) WILD-TYPE | 349 | 16 | 34 |
P value = 4.25e-06 (Wilcoxon-test), Q value = 0.0029
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 19(8P21.2) MUTATED | 104 | 68.0 (9.2) |
DEL PEAK 19(8P21.2) WILD-TYPE | 400 | 62.8 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 19(8P21.2) MUTATED | 23 | 6 | 75 |
DEL PEAK 19(8P21.2) WILD-TYPE | 357 | 15 | 29 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 20(9P23) MUTATED | 27 | 4 | 39 |
DEL PEAK 20(9P23) WILD-TYPE | 353 | 17 | 65 |
P value = 5.62e-10 (Wilcoxon-test), Q value = 3.9e-07
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 21(9Q21.2) MUTATED | 117 | 69.2 (9.0) |
DEL PEAK 21(9Q21.2) WILD-TYPE | 387 | 62.2 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 21(9Q21.2) MUTATED | 46 | 10 | 61 |
DEL PEAK 21(9Q21.2) WILD-TYPE | 334 | 11 | 43 |
P value = 3.56e-08 (Wilcoxon-test), Q value = 2.5e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 22(9Q34.2) MUTATED | 119 | 68.5 (8.6) |
DEL PEAK 22(9Q34.2) WILD-TYPE | 385 | 62.4 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 22(9Q34.2) MUTATED | 49 | 10 | 60 |
DEL PEAK 22(9Q34.2) WILD-TYPE | 331 | 11 | 44 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 23(10Q23.31) MUTATED | 29 | 5 | 34 |
DEL PEAK 23(10Q23.31) WILD-TYPE | 351 | 16 | 70 |
P value = 9.43e-06 (Wilcoxon-test), Q value = 0.0063
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 24(11P15.5) MUTATED | 94 | 68.2 (9.1) |
DEL PEAK 24(11P15.5) WILD-TYPE | 410 | 62.8 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 24(11P15.5) MUTATED | 32 | 5 | 57 |
DEL PEAK 24(11P15.5) WILD-TYPE | 348 | 16 | 47 |
P value = 0.000357 (Wilcoxon-test), Q value = 0.19
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 25(11Q14.1) MUTATED | 64 | 68.6 (9.1) |
DEL PEAK 25(11Q14.1) WILD-TYPE | 440 | 63.1 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 25(11Q14.1) MUTATED | 20 | 6 | 38 |
DEL PEAK 25(11Q14.1) WILD-TYPE | 360 | 15 | 66 |
P value = 0.000283 (Wilcoxon-test), Q value = 0.16
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 26(11Q25) MUTATED | 86 | 67.5 (10.0) |
DEL PEAK 26(11Q25) WILD-TYPE | 418 | 63.1 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 26(11Q25) MUTATED | 31 | 6 | 49 |
DEL PEAK 26(11Q25) WILD-TYPE | 349 | 15 | 55 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 27(12Q23.1) MUTATED | 11 | 3 | 32 |
DEL PEAK 27(12Q23.1) WILD-TYPE | 369 | 18 | 72 |
P value = 3.82e-05 (Wilcoxon-test), Q value = 0.022
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 28(12Q24.33) MUTATED | 56 | 69.4 (9.1) |
DEL PEAK 28(12Q24.33) WILD-TYPE | 448 | 63.1 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 28(12Q24.33) MUTATED | 16 | 2 | 38 |
DEL PEAK 28(12Q24.33) WILD-TYPE | 364 | 19 | 66 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 29(13Q11) MUTATED | 36 | 5 | 45 |
DEL PEAK 29(13Q11) WILD-TYPE | 344 | 16 | 59 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 30(13Q14.2) MUTATED | 48 | 6 | 39 |
DEL PEAK 30(13Q14.2) WILD-TYPE | 332 | 15 | 65 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 31(14Q13.1) MUTATED | 24 | 5 | 38 |
DEL PEAK 31(14Q13.1) WILD-TYPE | 356 | 16 | 66 |
P value = 4.08e-08 (Wilcoxon-test), Q value = 2.8e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 32(15Q15.1) MUTATED | 128 | 68.3 (9.7) |
DEL PEAK 32(15Q15.1) WILD-TYPE | 376 | 62.3 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 32(15Q15.1) MUTATED | 49 | 9 | 70 |
DEL PEAK 32(15Q15.1) WILD-TYPE | 331 | 12 | 34 |
P value = 1.23e-05 (Wilcoxon-test), Q value = 0.0071
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 33(15Q23) MUTATED | 107 | 67.6 (9.5) |
DEL PEAK 33(15Q23) WILD-TYPE | 397 | 62.8 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 33(15Q23) MUTATED | 37 | 7 | 63 |
DEL PEAK 33(15Q23) WILD-TYPE | 343 | 14 | 41 |
P value = 1.33e-06 (Wilcoxon-test), Q value = 9e-04
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 34(16P13.3) MUTATED | 83 | 69.0 (8.6) |
DEL PEAK 34(16P13.3) WILD-TYPE | 421 | 62.8 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 34(16P13.3) MUTATED | 24 | 5 | 54 |
DEL PEAK 34(16P13.3) WILD-TYPE | 356 | 16 | 50 |
P value = 2.59e-08 (Wilcoxon-test), Q value = 1.8e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 35(16Q21) MUTATED | 141 | 68.0 (9.2) |
DEL PEAK 35(16Q21) WILD-TYPE | 363 | 62.2 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 35(16Q21) MUTATED | 59 | 8 | 74 |
DEL PEAK 35(16Q21) WILD-TYPE | 321 | 13 | 30 |
P value = 1.78e-08 (Wilcoxon-test), Q value = 1.2e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 36(16Q22.3) MUTATED | 144 | 67.9 (9.0) |
DEL PEAK 36(16Q22.3) WILD-TYPE | 360 | 62.2 (11.6) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 36(16Q22.3) MUTATED | 63 | 8 | 73 |
DEL PEAK 36(16Q22.3) WILD-TYPE | 317 | 13 | 31 |
P value = 2.47e-08 (Wilcoxon-test), Q value = 1.7e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 37(16Q23.1) MUTATED | 152 | 67.7 (9.4) |
DEL PEAK 37(16Q23.1) WILD-TYPE | 352 | 62.2 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 37(16Q23.1) MUTATED | 65 | 7 | 80 |
DEL PEAK 37(16Q23.1) WILD-TYPE | 315 | 14 | 24 |
P value = 0.000294 (Wilcoxon-test), Q value = 0.16
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 38(17P13.3) MUTATED | 110 | 66.9 (9.1) |
DEL PEAK 38(17P13.3) WILD-TYPE | 394 | 63.0 (11.6) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 38(17P13.3) MUTATED | 42 | 9 | 59 |
DEL PEAK 38(17P13.3) WILD-TYPE | 338 | 12 | 45 |
P value = 5.37e-06 (Wilcoxon-test), Q value = 0.0036
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 39(17P11.2) MUTATED | 115 | 67.7 (9.4) |
DEL PEAK 39(17P11.2) WILD-TYPE | 389 | 62.7 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 39(17P11.2) MUTATED | 41 | 8 | 66 |
DEL PEAK 39(17P11.2) WILD-TYPE | 339 | 13 | 38 |
P value = 1.13e-06 (Wilcoxon-test), Q value = 0.00077
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 40(17Q11.2) MUTATED | 95 | 68.2 (9.4) |
DEL PEAK 40(17Q11.2) WILD-TYPE | 409 | 62.8 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 40(17Q11.2) MUTATED | 42 | 5 | 48 |
DEL PEAK 40(17Q11.2) WILD-TYPE | 338 | 16 | 56 |
P value = 1.77e-05 (Wilcoxon-test), Q value = 0.01
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 41(17Q21.31) MUTATED | 100 | 67.8 (9.9) |
DEL PEAK 41(17Q21.31) WILD-TYPE | 404 | 62.9 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 41(17Q21.31) MUTATED | 41 | 5 | 54 |
DEL PEAK 41(17Q21.31) WILD-TYPE | 339 | 16 | 50 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 42(18Q21.2) MUTATED | 35 | 6 | 41 |
DEL PEAK 42(18Q21.2) WILD-TYPE | 345 | 15 | 63 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 43(18Q23) MUTATED | 34 | 6 | 47 |
DEL PEAK 43(18Q23) WILD-TYPE | 346 | 15 | 57 |
P value = 1.45e-05 (logrank test), Q value = 0.0084
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 503 | 60 | 0.0 - 191.8 (22.8) |
DEL PEAK 44(19P13.3) MUTATED | 140 | 30 | 0.0 - 125.4 (19.7) |
DEL PEAK 44(19P13.3) WILD-TYPE | 363 | 30 | 0.1 - 191.8 (23.5) |
P value = 2.02e-10 (Wilcoxon-test), Q value = 1.4e-07
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 44(19P13.3) MUTATED | 141 | 68.5 (8.7) |
DEL PEAK 44(19P13.3) WILD-TYPE | 363 | 62.0 (11.6) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 44(19P13.3) MUTATED | 41 | 8 | 92 |
DEL PEAK 44(19P13.3) WILD-TYPE | 339 | 13 | 12 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 45(19P12) MUTATED | 19 | 5 | 28 |
DEL PEAK 45(19P12) WILD-TYPE | 361 | 16 | 76 |
P value = 0.00029 (logrank test), Q value = 0.16
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 503 | 60 | 0.0 - 191.8 (22.8) |
DEL PEAK 46(19Q13.43) MUTATED | 57 | 15 | 0.0 - 125.4 (20.0) |
DEL PEAK 46(19Q13.43) WILD-TYPE | 446 | 45 | 0.1 - 191.8 (23.1) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 46(19Q13.43) MUTATED | 15 | 4 | 39 |
DEL PEAK 46(19Q13.43) WILD-TYPE | 365 | 17 | 65 |
P value = 1.98e-05 (logrank test), Q value = 0.011
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 503 | 60 | 0.0 - 191.8 (22.8) |
DEL PEAK 47(20P12.1) MUTATED | 31 | 12 | 0.1 - 149.6 (20.0) |
DEL PEAK 47(20P12.1) WILD-TYPE | 472 | 48 | 0.0 - 191.8 (23.0) |
P value = 4.3e-08 (Wilcoxon-test), Q value = 3e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 48(22Q13.32) MUTATED | 129 | 68.5 (9.6) |
DEL PEAK 48(22Q13.32) WILD-TYPE | 375 | 62.2 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 48(22Q13.32) MUTATED | 51 | 10 | 68 |
DEL PEAK 48(22Q13.32) WILD-TYPE | 329 | 11 | 36 |
P value = 0.000365 (logrank test), Q value = 0.2
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 503 | 60 | 0.0 - 191.8 (22.8) |
DEL PEAK 49(XP21.1) MUTATED | 77 | 18 | 0.0 - 113.4 (17.9) |
DEL PEAK 49(XP21.1) WILD-TYPE | 426 | 42 | 0.1 - 191.8 (23.3) |
P value = 0.000263 (Wilcoxon-test), Q value = 0.14
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
DEL PEAK 49(XP21.1) MUTATED | 77 | 67.9 (9.4) |
DEL PEAK 49(XP21.1) WILD-TYPE | 427 | 63.1 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0067
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
DEL PEAK 49(XP21.1) MUTATED | 28 | 3 | 46 |
DEL PEAK 49(XP21.1) WILD-TYPE | 352 | 18 | 58 |
-
Copy number data file = transformed.cor.cli.txt
-
Clinical data file = UCEC-TP.merged_data.txt
-
Number of patients = 505
-
Number of significantly focal cnvs = 100
-
Number of selected clinical features = 7
-
Exclude genes that fewer than K tumors have mutations, K = 3
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.